Texas Statutes
Subchapter A. Prescription and Substitution Requirements
Section 562.015. Dispensing Directive; Compliance With Federal Law

Sec. 562.015. DISPENSING DIRECTIVE; COMPLIANCE WITH FEDERAL LAW. (a) The board shall adopt rules to provide a dispensing directive to instruct pharmacists on the manner in which to dispense a drug or biological product according to the contents of a prescription. The rules adopted under this section must:
(1) require the use of the phrase "brand necessary" or "brand medically necessary" on a prescription form to prohibit the substitution of a generically equivalent drug or interchangeable biological product for a brand name drug or biological product;
(2) be in a format that protects confidentiality as required by the Health Insurance Portability and Accountability Act of 1996 (Pub. L. No. 104-191) and its subsequent amendments;
(3) comply with federal and state law, including rules, with regard to formatting and security requirements;
(4) be developed to coordinate with 42 C.F.R. Section 447.512; and
(5) include an exemption for electronic prescriptions as provided by Subsection (b).
(b) The board shall provide an exemption from the directive adopted under this section for prescriptions transmitted electronically. The board may regulate the use of electronic prescriptions in the manner provided by federal law, including rules.
Added by Acts 2001, 77th Leg., ch. 1254, Sec. 7, eff. Sept. 1, 2001.
Amended by:
Acts 2015, 84th Leg., R.S., Ch. 1007 (H.B. 751), Sec. 13, eff. September 1, 2015.

Structure Texas Statutes

Texas Statutes

Occupations Code

Title 3 - Health Professions

Subtitle J - Pharmacy and Pharmacists

Chapter 562 - Practice by License Holder

Subchapter A. Prescription and Substitution Requirements

Section 562.001. Definitions

Section 562.002. Legislative Intent

Section 562.003. Disclosure of Price; Patient's Option

Section 562.004. Prescription Transmitted Orally by Practitioner

Section 562.005. Record of Dispensed Drug or Biological Product

Section 562.0051. Communication Regarding Certain Dispensed Biological Products

Section 562.006. Label

Section 562.0061. Other Prescription Information

Section 562.0062. Required Statement Regarding Medication Disposal

Section 562.007. Refills

Section 562.008. Generic Equivalent or Interchangeable Biological Product Authorized

Section 562.009. Requirements Concerning Selection of Generically Equivalent Drug or Interchangeable Biological Product

Section 562.010. Responsibility Concerning Generically Equivalent Drug or Interchangeable Biological Product; Liability

Section 562.011. Restriction on Selection of and Charging for Generically Equivalent Drug or Interchangeable Biological Product

Section 562.012. Substitution of Dosage Form Permitted

Section 562.013. Applicability of Subchapter

Section 562.014. Narrow Therapeutic Index Drugs

Section 562.0141. Transplant Immunosuppressant Drug Product Selection Prohibited

Section 562.0142. Adoption of Rules

Section 562.015. Dispensing Directive; Compliance With Federal Law

Section 562.016. List of Approved Interchangeable Biological Products